• NIH-funded trial to assess repurposed drugs for Covid-19 treatment pharmaceutical-technology
    April 21, 2021
    The National Institutes of Health (NIH) is set to fund the Phase III ACTIV-6 clinical trial to analyse various prescription and over-the-counter medications that are currently available for self-administration to treat Covid-19 symptoms.
PharmaSources Customer Service